JRCT ID: jRCT2080222866
Registered date:26/05/2015
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | The prevention of pertussis, diphtheria, tetanus, poliomyelitis, and infection caused by Haemophilus influenzae type b. |
Date of first enrollment | 26/05/2015 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : KD-370 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : 0.5 mL, Four doses, Subcutaneous injection |
Outcome(s)
Primary Outcome | |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | More than 2 months old, less than 60 months old |
Exclude criteria |
Related Information
Primary Sponsor | The Chemo-Sero-Therapeutic Research Institute |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-152918 |
Contact
Public contact | |
Name | |
Address | ikai-ctinfo@kaketsuken.or.jp |
Telephone | |
Affiliation | The Chemo-Sero-Therapeutic Research Institute |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |